drugset / Trial / NCT04926844

Effectiveness of Combined Levetiracetam and Midazolam in Generalized Convulsive Status Epilepticus in Children

NCT04926844

Phase 2 Completed 144 enrolled Sohag University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Generalized status epilepticus is a common pediatric neurological emergency with significant mortality and morbidity. Benzodiazepines remain the first anticonvulsive line but benzo-diazepines don't control seizures in about 30% of cases. GCSE may be more rapidly stopped and controlled through combining another drug with benzodiazepines such as Levetiracetam, acting by different pathways. This study aims to evaluate the effectiveness of combined levetiracetam and midazolam in treatment of generalized convulsive status epilepticus in children.

Timeline

Start
2021-06-20
Primary completion
2022-08-30
Completion
2022-09-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Levetiracetam Other / unclassified 60 mg/kg Intravenous
Background Midazolam Small molecule 0.2 mg/kg Intravenous